Literature DB >> 12868497

Assessment of cardiovascular autonomic function in myotonic dystrophy type 2 (DM2/PROMM).

Peter Flachenecker1, Christiane Schneider, Simone Cursiefen, Kenneth Ricker, Klaus V Toyka, Karlheinz Reiners.   

Abstract

BACKGROUND: Proximal myotonic myopathy is an autosomal dominant multisystem disorder with a recently defined CCTG expansion on chromosome 3 in the major subgroup (myotonic dystrophy type 2). Cardiac rhythm disturbances have been described in patients with this disease, but it is not known whether myotonic dystrophy type 2/proximal myotonic myopathy patients suffer from dysautonomia and whether cardiac arrhythmias relate to autonomic dysfunction.
OBJECTIVES: To investigate cardiovascular autonomic function in myotonic dystrophy type 2/proximal myotonic myopathy patients with and without cardiac arrhythmias. PATIENTS AND METHODS: Standard autonomic function tests (heart rate responses to Valsalva manoeuvre, deep breathing and active change of posture, and blood pressure responses to active change of posture and sustained handgrip), resting heart rate variability in the time- and frequency-domain, and the corrected QT interval length were determined in 16 patients with genetically defined myotonic dystrophy type 2/proximal myotonic myopathy and compared to the results obtained in 16 age- and sex-matched healthy control subjects.
RESULTS: Standard autonomic tests yielded similar results in both groups. Measures of heart rate variability tended to be lower in myotonic dystrophy type 2/proximal myotonic myopathy patients compared to healthy controls, but reached statistical significance only for the number of R-R intervals exceeding 50 ms (p50) and the power spectrum density in the low-frequency range (low-frequency power). Four patients (25%) suffered from mild cardiac rhythm disturbances encompassing paroxysmal tachycardia, sinoatrial block, right bundle branch block, ventricular premature beats and bradycardia. The autonomic responses of these patients were essentially similar compared to those without cardiac arrhythmias, apart from a decreased heart rate response to deep breathing in the patients with cardiac arrhythmias.
CONCLUSIONS: We found no major abnormalities of cardiovascular autonomic function in patients with myotonic dystrophy type 2/proximal myotonic myopathy, neither in the whole study group nor in the subgroup of patients with cardiac rhythm abnormalities.

Entities:  

Mesh:

Year:  2003        PMID: 12868497     DOI: 10.1016/s0960-8966(02)00277-8

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

Review 1.  Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  Neurol Sci       Date:  2017-01-11       Impact factor: 3.307

2.  Female patient with proximal myotonic myopathy and ventricular tachycardia.

Authors:  S Schenk; S Löscher; F Mickley; A Hartmann
Journal:  Z Kardiol       Date:  2005-11

3.  Cardiac autonomic function in type 1 and type 2 myotonic dystrophy.

Authors:  Piotr Bienias; Anna Łusakowska; Michał Ciurzyński; Zuzanna Rymarczyk; Katarzyna Irzyk; Michał Konwerski; Kamil Ciąpała; Paweł Kowalski; Anna Kamińska; Piotr Pruszczyk
Journal:  Clin Auton Res       Date:  2017-03-20       Impact factor: 4.435

Review 4.  Myotonic dystrophy type 2 and related myotonic disorders.

Authors:  Giovanni Meola; Richard T Moxley
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

Review 5.  Usefulness of heart rate variability as a predictor of sudden cardiac death in muscular dystrophies.

Authors:  L Politano; A Palladino; G Nigro; M Scutifero; V Cozza
Journal:  Acta Myol       Date:  2008-12

Review 6.  Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.

Authors:  Giovanni Meola
Journal:  Acta Myol       Date:  2013-12

7.  Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.

Authors:  Giovanni Meola; Rosanna Cardani
Journal:  J Neuromuscul Dis       Date:  2015-07-22

Review 8.  Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila.

Authors:  Mouli Chakraborty; Beatriz Llamusi; Ruben Artero
Journal:  Front Neurol       Date:  2018-07-16       Impact factor: 4.003

9.  Myotonic dystrophy type 2: the 2020 update.

Authors:  Giovanni Meola
Journal:  Acta Myol       Date:  2020-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.